U.S. Personal Products Stock News

NYSE:NUE
NYSE:NUEMetals and Mining

Nucor Leadership Shift And Reinvestment Plans Put Execution In Focus

Nucor (NYSE:NUE) has finalized a future retirement agreement for executive David A. Sumoski. The agreement sets out ongoing non compete and confidentiality obligations after his departure. The transition coincides with Nucor's major reinvestment program and capacity expansion plans. Nucor operates as a large steel producer, and its leadership structure matters for how it runs mills, manages raw materials, and allocates capital. The timing of David A. Sumoski’s planned retirement, paired...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

A Look At TMC The Metals (TMC) Valuation After Permit Progress And Allseas Mining Agreement

TMC the metals (TMC) has been back in focus after US regulators confirmed its deep sea mining application is fully compliant, while a new Allseas agreement mapped out the first commercial nodule collection system. See our latest analysis for TMC the metals. The latest regulatory green light and Allseas agreement have come after a period where the share price has risen 14.31% over the past month yet is still down 11.65% year to date. At the same time, the 1 year total shareholder return of...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen’s Salanersen Win Adds New Dimension To SMA Growth Story

Biogen (NasdaqGS:BIIB) received FDA Breakthrough Therapy Designation for salanersen, an investigational once-yearly treatment for spinal muscular atrophy (SMA). The designation is based on clinical data that the FDA views as potentially meaningful for patients with SMA. This marks a fresh regulatory milestone for Biogen that is separate from its previously covered lupus and Parkinson's programs. For investors tracking Biogen at a share price of $196.45, the salanersen news adds a new angle...
NYSE:AI
NYSE:AISoftware

C3.ai (AI) Losses Deepen To US$470 Million Trailing Challenging Bullish AI Narratives

C3.ai (AI) just posted its FY 2026 fourth quarter numbers, with revenue at US$51.6 million and a basic EPS loss of US$0.79, alongside a trailing 12 month revenue base of US$250.3 million and a trailing EPS loss of US$3.35. Over recent quarters, the company has seen quarterly revenue move from US$108.7 million in Q4 FY 2025 to US$51.6 million in Q4 FY 2026, while quarterly basic EPS losses ranged between US$0.60 and US$0.94. This sets up an earnings print where the focus is firmly on how...
NYSE:ABM
NYSE:ABMCommercial Services

Assessing ABM Industries (ABM) Valuation After Recent Share Weakness And 22.5% Undervaluation Narrative

ABM Industries stock reaction and recent share performance ABM Industries (ABM) has drawn investor attention after recent trading moves, with the stock last closing at $39.88. Shares are down about 2% over the past month and roughly 9% over the past 3 months. See our latest analysis for ABM Industries. Set against that shorter term weakness, ABM Industries has had a softer run overall, with the share price return down year to date and the 1 year total shareholder return also in decline. This...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork (UPWK) Valuation Check As New Board Appointments Aim To Strengthen Governance And Future Growth

What Upwork’s New Board Appointments Could Mean for Investors Upwork (UPWK) has drawn fresh attention after appointing Claire Bramley and David Lissy to its Board of Directors, both joining the Audit, Risk, and Compliance Committee following the June 4, 2026 stockholder meeting. For you as an investor, this kind of board refresh is less about headlines and more about what it could imply for oversight of finances, risk, and long term decision making at a company that sits at the center of...
NasdaqCM:PROK
NasdaqCM:PROKBiotechs

Identiv And Two Other Penny Stocks To Watch Closely

The market remained flat over the last week, but it is up 26% over the past year, with earnings forecast to grow by 16% annually. For investors willing to look beyond the big names, penny stocks can present intriguing opportunities for growth at lower price points. While often associated with smaller or newer companies, these stocks can offer potential upside when backed by strong fundamentals and sound balance sheets.
NYSE:CRCL
NYSE:CRCLSoftware

Exploring 3 High Growth Tech Stocks In The US Market

Over the last 7 days, the United States market has remained flat, yet it is up 26% over the past year with earnings expected to grow by 16% per annum over the next few years. In this context, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and strong potential to capitalize on future market trends.
NYSE:DNOW
NYSE:DNOWTrade Distributors

3 Stocks That Could Be Trading At A Discount Of Up To 34.5%

The United States market has shown a remarkable 26% increase over the past year, despite remaining flat over the last week, with expectations for earnings to grow by 16% annually in the coming years. In this context, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities that align with these growth prospects and current market stability.
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Top Growth Companies With Insider Ownership In June 2026

The United States market remained flat over the last week but has seen a robust 26% increase over the past year, with earnings expected to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly attractive as they often indicate strong internal confidence and alignment of interests between management and shareholders.
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Top Dividend Stocks To Consider In June 2026

The United States market has remained flat over the last week but is up 26% over the past year, with earnings expected to grow by 16% annually. In this context of robust growth expectations, dividend stocks can offer a compelling blend of income and potential capital appreciation, making them an attractive option for investors seeking stability and returns.
NYSE:LXP
NYSE:LXPIndustrial REITs

A Look At LXP Industrial Trust (LXP) Valuation After Recent Share Price Momentum

Event overview and recent share performance LXP Industrial Trust (LXP) shares recently moved about 3.1% in a single session, drawing attention to how this warehouse focused REIT has been trading over the past month and the past 3 months. See our latest analysis for LXP Industrial Trust. That 3.1% one day share price move comes after an 8.5% share price return over the past 3 months and a 27.5% total shareholder return over the past year. This suggests momentum has been building rather than...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Valuation After Watchman Concerns And Softer Guidance Pressure The Share Price

Boston Scientific (BSX) is under pressure after cautious analyst commentary, including a Wolfe Research downgrade tied to slower Watchman implant sales, along with softer full-year guidance despite Q1 revenue exceeding expectations. See our latest analysis for Boston Scientific. The recent six day slide and softer guidance have pulled Boston Scientific’s share price down 12.7% over the past month and 48.4% year to date, with 1 year total shareholder return down 52.5%. This shows momentum has...
NasdaqGS:LIN
NasdaqGS:LINChemicals

Assessing Linde (LIN) Valuation After Q1 2026 Earnings Beat And Raised Guidance

Why Linde’s latest earnings beat is drawing fresh attention Linde (NasdaqGS:LIN) has moved back into focus after Q1 2026 earnings and revenue topped expectations and management raised full year and second quarter guidance, prompting higher conviction among research firms. For you as a shareholder or potential buyer, that upbeat guidance and analyst commentary are tied to very specific areas, including hydrogen, electronics gases, clean energy projects, and Linde’s growing role in supporting...
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Is It Time To Reassess Tenable Holdings (TENB) After The Recent Share Price Surge

Wondering whether Tenable Holdings at around US$29.29 is starting to look like value, or if the stock still carries more risk than reward. The share price has moved sharply in the short term, with returns of 12.9% over the past week and 39.3% over the past month, while year to date the stock is up 28.9%. However, it has fallen 10.0% over the past year, 26.5% over three years and 31.9% over five years. Recent coverage has focused on Tenable Holdings as a cybersecurity platform provider, with...
NasdaqGS:MLCO
NasdaqGS:MLCOHospitality

A Look At Melco Resorts & Entertainment (NasdaqGS:MLCO) Valuation After Mixed Recent Share Price Performance

Melco Resorts & Entertainment overview Melco Resorts & Entertainment (MLCO) has drawn fresh attention after recent trading, with the stock closing at $5.82 and showing mixed returns over the past month and the past three months. See our latest analysis for Melco Resorts & Entertainment. The recent 8.6% 1 month share price return and 5.1% 7 day move contrast with a year to date share price decline of 22.5%, while the 5 year total shareholder return has fallen 66.3%. This highlights short term...
NYSE:FUN
NYSE:FUNHospitality

A Look At Six Flags Entertainment (FUN) Valuation As Membership Expansion Targets Recurring Revenue

Membership expansion sets the stage for recurring revenue focus Six Flags Entertainment (FUN) is extending its Membership program to six more parks starting June 8, giving guests broader multi park access with low monthly payments and putting recurring revenue squarely in focus. For you as an investor, this type of membership expansion matters because it shifts more of the company’s business toward ongoing payments, rather than relying solely on individual ticket sales or seasonal spikes in...
NYSE:VIA
NYSE:VIASoftware

Via Transportation Probe Raises Questions On Disclosures And Investor Risk Profile

Securities law firm announces investigation into Via Transportation (NYSE:VIA) for potential securities law violations. Focus of the probe is on whether Via Transportation made inaccurate statements about its financials and business operations. Investigation could have implications for current and prospective shareholders depending on its findings. Via Transportation, listed on the NYSE under ticker VIA, operates in the technology enabled transit and mobility services space, connecting...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Assessing Rhythm Pharmaceuticals (RYTM) Valuation As Rare Disease Growth Story Faces High Sales Multiple

Stock performance snapshot and business overview Rhythm Pharmaceuticals (RYTM) has seen mixed trading recently, with the stock up 3.4% over the past day but down over the past week, month and past 3 months. Year to date, the share price is also lower. Over a longer horizon, total return over the past year is positive, and over the past 3 and 5 years the stock shows very large cumulative gains. The current share price is US$87.61, giving the company a market value of about US$5.8b. Rhythm...
NYSE:SPGI
NYSE:SPGICapital Markets

A Look At S&P Global (SPGI) Valuation After Recent Share Price Weakness

Recent performance snapshot S&P Global (SPGI) stock has fallen about 18% year to date, with total return over the past year also down roughly 18%. This puts recent performance in contrast with its longer term multi year record. See our latest analysis for S&P Global. The recent 1 day share price return of 1.9% to US$420.12 comes after a steady loss of momentum, with the 90 day share price return down 7.1% and the 1 year total shareholder return down 17.9%, even though the 5 year total...
NYSE:U
NYSE:USoftware

Unity Software (U) Valuation Check As Analyst Upgrades Follow Grow Ad Business Progress

Unity Software (U) is back in focus after recent analyst upgrades, including commentary on progress in its Grow advertising business and higher earnings estimates that together underline shifting expectations around the company’s execution and monetization. See our latest analysis for Unity Software. Unity’s recent analyst upgrades and improving sentiment around its Grow ad business sit alongside a mixed price story, with the stock’s 90 day share price return of 51.28% contrasting with a year...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Kodiak Sciences Zenkuda Trial Win Puts Cash Needs And Growth In Focus

Kodiak Sciences (NasdaqGM:KOD) reported positive phase III results for its drug candidate Zenkuda in diabetic retinopathy. The company is accelerating regulatory submissions following the data readout, aiming to move the program toward potential approval. Kodiak Sciences is drawing fresh attention after this clinical update, with the stock at $34.16 and up strongly year to date, including a very large gain over the past 1 year. At the same time, shares are down 5.4% over the past week and...
NYSE:OSK
NYSE:OSKMachinery

How New Autonomy and Tactical Vehicle Contracts At Oshkosh (OSK) Have Changed Its Investment Story

In recent days, Oshkosh Defense, a business of Oshkosh Corporation, announced multiple past contract wins with the U.S. Marine Corps, including US$92,000,000 in ROGUE-Fires Block 2 production orders for semi-autonomous ground vehicles and US$142,000,000 in new Family of Medium Tactical Vehicles A2 orders from U.S. and international customers. These awards highlight Oshkosh’s growing role in autonomous ground combat systems and modern tactical fleets, reinforcing its exposure to large,...
NYSE:KVUE
NYSE:KVUEPersonal Products

Is It Time To Reassess Kenvue (KVUE) After Recent Share Price Weakness?

If you are wondering whether Kenvue's current share price offers value, or if you are better off waiting on the sidelines, this article breaks down what the market is pricing in and how that compares with several valuation checks. The stock recently closed at US$16.88 and has fallen 4.3% over the last week, 2.8% over the last month, and 2.5% year to date. The return over the past year is down 18.4% and down 24.1% over three years. Recent news flow around Kenvue has focused on its position as...